Humacyte, Inc.
USD0.79
-0.01 (-1.34%)
CEO
Laura E. Niklason
IPO Date
2020-12-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.77
Prev. Close
$0.80
Day Low
$0.76
Day High
$0.87
52W Low
$0.55
52W High
$2.84
Market Cap
$0.13B
Volume
10.94M
| -4.0 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -817.8% | -86.4% | 4.24 | 4.52 | -2.7 |
| 31 Dec 2022 | FY | -427.5% | -764.5% | -10.2% | -5.9% | 0.43 | 7.88 | -18.2 |
| 31 Dec 2021 | FY | -4756.8% | -2096.4% | -21.7% | -9.2% | 0.42 | 20.75 | -10.9 |
| 31 Dec 2020 | FY | -3527.0% | -4461.7% | -94.1% | -62.4% | 0.41 | 3.69 | -1.9 |
| 31 Dec 2019 | FY | -1122.0% | -1380.7% | -64.6% | -50.6% | 0.22 | 8.76 | -2.3 |
| -1.5 |
| 30 Sept 2025 | Q3 | -182.2% | -2325.4% | 368.6% | -19.1% | -6.28 | 1.62 | -3.9 |
| 30 Jun 2025 | Q2 | -588.7% | -12511.0% | -929.4% | -27.1% | 20.72 | 2.45 | -2.2 |
| 31 Mar 2025 | Q1 | -282.8% | 7570.4% | 108.6% | 24.1% | 0.44 | 3.68 | 1.4 |
| 31 Dec 2024 | Q4 | 50.0% | -289.7% | 39.8% | -15.2% | -0.31 | 2.40 | -7.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | 61.5% | -34.2% | -0.27 | 1.10 | -4.1 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | 200.3% | -41.0% | -0.63 | 5.41 | -2.8 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -122.0% | -19.8% | 0.71 | 8.37 | -2.6 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -185.3% | -19.6% | 4.25 | 4.52 | -2.9 |